• In recent days, AngloGold Ashanti has drawn attention after analyst earnings estimate revisions turned weaker and its Zacks Rank dropped, even as the company advances capital-intensive projects such as the Arthur Gold Project in Nevada.
• This split between upbeat brokerage recommendations and more cautious earnings expectations highlights growing debate over whether new reserves can offset rising costs and fiscal pressures on future profitability.
• We’ll now explore how this tension between positive brokerage views and weaker earnings revisions may reshape AngloGold Ashanti’s investment narrative.

Invest in the nuclear renaissance through our list of 92 elite nuclear energy infrastructure plays powering the global AI revolution.

AngloGold Ashanti Investment Narrative Recap

To be a shareholder in AngloGold Ashanti, you need to believe that its global gold portfolio and new Nevada projects can sustain strong cash generation despite rising costs and fiscal pressures. The recent split between upbeat brokerage ratings and weaker earnings revisions does not change the near term catalyst of delivering on current guidance, but it sharpens focus on the key risk that cost inflation and higher royalties may squeeze margins faster than new reserves can contribute.

The Arthur Gold Project update is central here. Its 4.9 million ounce probable reserve and projected all in sustaining cost of about US$954 per ounce speak directly to whether AngloGold Ashanti can support future cash flows while offsetting inflation and higher government take. Against the backdrop of softer production in H1 2026 and a lower Zacks Rank, Arthur’s economics are likely to be a key reference point for how investors weigh the stock’s recent strong share price run.

Yet beneath the upbeat long term story, investors should be aware that rising operating and fiscal burdens could eventually...

AngloGold Ashanti’s narrative projects $12.1 billion revenue and $5.5 billion earnings by 2029. This requires fairly flat yearly revenue growth and a $1.7 billion earnings increase from $3.8 billion today.

Uncover how AngloGold Ashanti's forecasts yield a $113.12 fair value, a 6% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were once banking on revenue reaching about US$20,000,000,000 and earnings of roughly US$6,400,000,000, yet the latest downgrade in earnings estimates and cost concerns at Arthur highlight how differently you and other shareholders might now weigh that bullish view against the ongoing risk of rising operating costs in challenging regions.

Explore 5 other fair value estimates on AngloGold Ashanti - why the stock might be worth 6% less than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your AngloGold Ashanti research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free AngloGold Ashanti research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate AngloGold Ashanti's overall financial health at a glance.

Seeking Other Investments?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Outshine the giants: these 18 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.